Back

Atrial fibrillation after closure of persistent foramen ovale in the REDUCE clinical trial.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Stroke - Heart: clinical interactions Patent Foramen Ovale and Patent Foramen Ovale (PFO) Closure ESC Premium Access ESC Congress 2018

About the speaker

Photo
Associate Professor Asger Andersen

Aarhus University Hospital, Aarhus (Denmark)

9 More presentations in this session

Presentation thumbnail
The left atrial appendage morphology correlates with stroke risk in patients with sinus rhythm
Doctor N. Herman (Krakow, PL)
Abstract
Presentation thumbnail
Use of routine E/A ratio echocardiographic following cerebral ischemia is associated with paroxysmal atrial fibrillation
Doctor C. Bergerot (Lyon, FR)
Abstract Slides
Presentation thumbnail
High proportion of ischemic strokes may be due to low adherence to oral anticoagulation guidelines among patients with atrial fibrillation and stroke risk factors
Professor G. Boriani (Modena, IT)
Abstract
Presentation thumbnail
Impact of admission plasma D-dimer level on short-term risk of ischemic stroke in hospitalized patients with acute heart failure
Doctor Y. Hamatani (Boston, US)
Abstract Slides
Presentation thumbnail
Endothelial dysfunction as a potential link between interatrial septal abnormalities and methylene tetrahydrofolate reductase (MTHFR)-inherited thrombophilia. A preliminary study on cryptogenic stroke
Doctor L. Sgarra (Acquaviva Delle Fonti, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Stroke - Heart: clinical interactions

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources